Literature DB >> 23653106

Evaluation of the skin peptide defenses of the Oregon spotted frog Rana pretiosa against infection by the chytrid fungus Batrachochytrium dendrobatidis.

J Michael Conlon1, Laura K Reinert, Milena Mechkarska, Manju Prajeep, Mohammed A Meetani, Laurent Coquet, Thierry Jouenne, Marc P Hayes, Gretchen Padgett-Flohr, Louise A Rollins-Smith.   

Abstract

Population declines due to amphibian chytridiomycosis among selected species of ranid frogs from western North America have been severe, but there is evidence that the Oregon spotted frog, Rana pretiosa Baird and Girard, 1853, displays resistance to the disease. Norepinephrine-stimulated skin secretions were collected from a non-declining population of R. pretiosa that had been exposed to the causative agent Batrachochytrium dendrobatidis. Peptidomic analysis led to identification and isolation, in pure form, of a total of 18 host-defense peptides that were characterized structurally. Brevinin-1PRa, -1PRb, -1PRc, and -1PRd, esculentin-2PRa and -PRb, ranatuerin-2PRa, -2PRb, -2PRc, and -2PRe, temporin-PRb and -PRc were identified in an earlier study of skin secretions of frogs from a different population of R. pretiosa known to be declining. Ranatuerin-2PRf, -2PRg, -2PRh, temporin-PRd, -PRe, and -PRf were not identified in skin secretions from frogs from the declining population, whereas temporin-PRa and ranatuerin-2PRd, present in skin secretions from the declining population, were not detected in the current study. All purified peptides inhibited the growth of B. dendrobatidis zoospores. Peptides of the brevinin-1 and esculentin-2 families displayed the highest potency (minimum inhibitory concentration = 6.25-12.5 μM). The study provides support for the hypothesis that the multiplicity and diversity of the antimicrobial peptide repertoire in R. pretiosa and the high growth-inhibitory potency of certain peptides against B. dendrobatidis are important in conferring a measure of resistance to fatal chytridiomycosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23653106     DOI: 10.1007/s10886-013-0294-z

Source DB:  PubMed          Journal:  J Chem Ecol        ISSN: 0098-0331            Impact factor:   2.626


  25 in total

Review 1.  The contribution of skin antimicrobial peptides to the system of innate immunity in anurans.

Authors:  J Michael Conlon
Journal:  Cell Tissue Res       Date:  2010-07-17       Impact factor: 5.249

2.  Transmission of Batrachochytrium dendrobatidis to wood frogs (Lithobates sylvaticus) via a bullfrog (L. catesbeianus) vector.

Authors:  Sasha E Greenspan; Aram J K Calhoun; Joyce E Longcore; Michael G Levy
Journal:  J Wildl Dis       Date:  2012-07       Impact factor: 1.535

3.  Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis.

Authors:  J Michael Conlon; Milena Mechkarska; Eman Ahmed; Laurent Coquet; Thierry Jouenne; Jérôme Leprince; Hubert Vaudry; Marc P Hayes; Gretchen Padgett-Flohr
Journal:  Dev Comp Immunol       Date:  2011-02-01       Impact factor: 3.636

4.  Transmission of Batrachochytrium dendrobatidis within and between amphibian life stages.

Authors:  Lara J Rachowicz; Vance T Vredenburg
Journal:  Dis Aquat Organ       Date:  2004-10-21       Impact factor: 1.802

5.  Variations in the expressed antimicrobial peptide repertoire of northern leopard frog (Rana pipiens) populations suggest intraspecies differences in resistance to pathogens.

Authors:  Jacob A Tennessen; Douglas C Woodhams; Pierre Chaurand; Laura K Reinert; Dean Billheimer; Yu Shyr; Richard M Caprioli; Michael S Blouin; Louise A Rollins-Smith
Journal:  Dev Comp Immunol       Date:  2009-08-03       Impact factor: 3.636

6.  Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae.

Authors:  J Michael Conlon
Journal:  Peptides       Date:  2008-06-08       Impact factor: 3.750

Review 7.  Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time, and host.

Authors:  Matthew C Fisher; Trenton W J Garner; Susan F Walker
Journal:  Annu Rev Microbiol       Date:  2009       Impact factor: 15.500

Review 8.  The role of amphibian antimicrobial peptides in protection of amphibians from pathogens linked to global amphibian declines.

Authors:  Louise A Rollins-Smith
Journal:  Biochim Biophys Acta       Date:  2009-03-25

9.  Pathophysiology in mountain yellow-legged frogs (Rana muscosa) during a chytridiomycosis outbreak.

Authors:  Jamie Voyles; Vance T Vredenburg; Tate S Tunstall; John M Parker; Cheryl J Briggs; Erica Bree Rosenblum
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 10.  Immune defenses of Xenopus laevis against Batrachochytrium dendrobatidis.

Authors:  Louise A Rollins-Smith; Jeremy P Ramsey; Laura K Reinert; Douglas C Woodhams; Lauren J Livo; Cynthia Carey
Journal:  Front Biosci (Schol Ed)       Date:  2009-06-01
View more
  4 in total

1.  Infection dynamics in frog populations with different histories of decline caused by a deadly disease.

Authors:  Sarah J Sapsford; Maarten J Voordouw; Ross A Alford; Lin Schwarzkopf
Journal:  Oecologia       Date:  2015-08-21       Impact factor: 3.225

2.  Frog skin cultures secrete anti-yellow fever compounds.

Authors:  Carolina Muñoz-Camargo; Margarita Correa Méndez; Vivian Salazar; Johanna Moscoso; Diana Narváez; Maria Mercedes Torres; Franz Kaston Florez; Helena Groot; Eduardo Mitrani
Journal:  J Antibiot (Tokyo)       Date:  2016-04-06       Impact factor: 2.649

3.  Antimicrobial peptides from Rana [Lithobates] catesbeiana: Gene structure and bioinformatic identification of novel forms from tadpoles.

Authors:  Caren C Helbing; S Austin Hammond; Shireen H Jackman; Simon Houston; René L Warren; Caroline E Cameron; Inanç Birol
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

Review 4.  Frog Skin Innate Immune Defences: Sensing and Surviving Pathogens.

Authors:  Joseph F A Varga; Maxwell P Bui-Marinos; Barbara A Katzenback
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.